BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bavato F, Cathomas F, Klaus F, Gütter K, Barro C, Maceski A, Seifritz E, Kuhle J, Kaiser S, Quednow BB. Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum. J Psychiatr Res 2021;140:141-8. [PMID: 34116440 DOI: 10.1016/j.jpsychires.2021.05.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Runge K, Balla A, Fiebich BL, Maier SJ, von Zedtwitz K, Nickel K, Dersch R, Domschke K, Tebartz van Elst L, Endres D. Neurodegeneration Markers in the Cerebrospinal Fluid of 100 Patients with Schizophrenia Spectrum Disorder. Schizophr Bull 2023;49:464-73. [PMID: 36200879 DOI: 10.1093/schbul/sbac135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bai YM, Liu YL, Kuo HW, Tsai SJ, Hsu JW, Huang KL, Tu PC, Chen MH. Procollagen type 1 N-terminal propeptide, neurofilament light chain, proinflammatory cytokines, and cognitive function in bipolar and major depressive disorders: An exploratory study of brain- bone axis and systemic inflammation. J Psychiatr Res 2023;158:403-8. [PMID: 36657346 DOI: 10.1016/j.jpsychires.2023.01.012] [Reference Citation Analysis]
3 Huang MC, Chen CH, Liu TH, Chung AN, Liu YL, Quednow BB, Bavato F. Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology. J Psychiatr Res 2023;158:360-4. [PMID: 36640660 DOI: 10.1016/j.jpsychires.2023.01.009] [Reference Citation Analysis]
4 Zhang H. Association of Serum Neurofilament Light Chain with Depressive Symptoms: a population-based study.. [DOI: 10.21203/rs.3.rs-2337172/v1] [Reference Citation Analysis]
5 Chen WY, Huang MC, Chiu CC, Cheng YC, Kuo CJ, Chen PY, Kuo PH. The interactions between vitamin D and neurofilament light chain levels on cognitive domains in bipolar disorder. BJPsych Open 2022;8:e207. [PMID: 36437810 DOI: 10.1192/bjo.2022.608] [Reference Citation Analysis]
6 Eratne D, Janelidze S, Malpas CB, Loi S, Walterfang M, Merritt A, Diouf I, Blennow K, Zetterberg H, Cilia B, Wannan C, Bousman C, Everall I, Zalesky A, Jayaram M, Thomas N, Berkovic SF, Hansson O, Velakoulis D, Pantelis C, Santillo A; MiND Study Group. Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives. Aust N Z J Psychiatry 2022;56:1295-305. [PMID: 35179048 DOI: 10.1177/00048674211058684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Al-hakeim HK, Al-naqeeb TH, Almulla AF, Maes M. The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with peripheral inflammation, insulin resistance and lowered calcium.. [DOI: 10.1101/2022.07.04.22277246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nicoletti TF, Rossi S, Vita MG, Perna A, Guerrera G, Lino F, Iacovelli C, Di Natale D, Modoni A, Battistini L, Silvestri G. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1). J Neurol. [DOI: 10.1007/s00415-022-11165-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bavato F, Stamatakos S, Ohki CMY, Seifritz E, Romualdi P, Grünblatt E, Quednow BB. Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine ("Ecstasy") induced cytoskeletal damage. J Neural Transm (Vienna) 2022. [PMID: 35420371 DOI: 10.1007/s00702-022-02502-8] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang J, Cheng H, Liu W, Li H, Song Y, Jia L. Neurofilament light chain in cerebrospinal fluid or blood as a biomarker for mild cognitive impairment: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28932. [PMID: 35244049 DOI: 10.1097/MD.0000000000028932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Aggio V, Fabbella L, Finardi A, Mazza EB, Colombo C, Falini A, Benedetti F, Furlan R. Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder. J Affect Disord 2022;300:243-8. [PMID: 34979181 DOI: 10.1016/j.jad.2021.12.122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bavato F, Kexel A, Kluwe-schiavon B, Maceski A, Baumgartner M, Seifritz E, Kuhle J, Quednow B. A longitudinal investigation of blood neurofilament light chain levels in chronic cocaine users.. [DOI: 10.1101/2022.02.03.22270384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hołub T, Kędzierska K, Muras-Szwedziak K, Nowicki M. Serum neurofilament light chain is not a useful biomarker of central nervous system involvement in women with Fabry disease. Intractable Rare Dis Res 2021;10:276-82. [PMID: 34877240 DOI: 10.5582/irdr.2021.01115] [Reference Citation Analysis]
14 Klaus F, Guetter K, Schlegel R, Spiller TR, Seifritz E, Cathomas F, Kaiser S. Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia. Sci Rep 2021;11:19204. [PMID: 34584171 DOI: 10.1038/s41598-021-98769-0] [Reference Citation Analysis]
15 Wang DZ, Guo FQ, Guo L, Yang S, Yu NW, Wang J, Wang JH. Serum Neurofilament Light Predicts 6-Month Mental Health Outcomes in a Cohort of Patients With Acute Ischemic Stroke. Front Psychiatry 2021;12:764656. [PMID: 35197872 DOI: 10.3389/fpsyt.2021.764656] [Reference Citation Analysis]